Definition and classification of pulmonary hypertension

Handbook of Experimental Pharmacology

Volumn 218, Issue , 2013, Pages 3-29

  Humbert, Marc ^a,b,c   Montani, David ^a,b,c   Evgenov, Oleg V ^d   Simonneau, Gérald ^a,b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^c BICÊTRE HOSPITAL   (France)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Pulmonary arterial hypertension; Pulmonary artery pressure; Pulmonary hypertension; Right heart catheterization

Indexed keywords

BENFLUOREX; DEXFENFLURAMINE; FENFLURAMINE; RAPESEED OIL;

ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CONGENITAL HEART DISEASE; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; DRUG INDUCED PULMONARY HYPERTENSION; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXIA; IDIOPATHIC DISEASE; LUNG ARTERY PRESSURE; LUNG DISEASE; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; METABOLIC DISORDER; PORTOPULMONARY HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VENO-OCCLUSIVE DISEASE; RISK FACTOR; SCHISTOSOMIASIS; SYSTEMIC DISEASE; TOXIN INDUCED PULMONARY HYPERTENSION;

ANIMALS; HUMANS; HYPERTENSION, PULMONARY;

EID: 84893033214     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-38664-0_1     Document Type: Article

References (115)

1. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simonneau G, Bégaud B (1996) Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 335:609-616
2. Adir Y, Humbert M (2010) Pulmonary hypertension in patients with chronic myeloproliferative disorders. Eur Respir J 35:1396-1406
3. Aessopos A, Stamatelos G, Skoumas V, Vassilopoulos G, Mantzourani M, Loukopoulos D (1995) Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia. Chest 107:50-53
4. Anderson MB, Kriett JM, Kapelanski DP, Tarazi R, Jamieson SW (1995) Primary pulmonary artery sarcoma: A report of six cases. Ann Thorac Surg 59:1487-1490
5. Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GR (1990) Pulmonary hypertension in a lupus clinic: Experience with twenty-four patients. J Rheumatol 17:1292-1298
6. Badesch DB, Wynne KM, Bonvallet S, Voelkel NF, Ridgway C, Groves BM (1993) Hypothyroidism and primary pulmonary hypertension: An autoimmune pathogenetic link Ann Intern Med 119:44-46
7. Boutet K, Frachon I, Jobic Y, Gut-Gobert C, Leroyer C, Carlhant-Kowalski D, Sitbon O, Simonneau G, Humbert M (2009) Fenfluramine-like cardiovascular side-effects of benfluorex. Eur Respir J 33:684-688
8. Brenot F, Hervé P, Petitpretz P, Parent F, Duroux P, Simonneau G (1993) Primary pulmonary hypertension and fenfluramine use. Br Heart J 70:537-541
9. Bunch TW, Tancredi RG, Lie JT (1981) Pulmonary hypertension in polymyositis. Chest 79: 105-107
10. Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC (1999) Long-term outcome in mixed connective tissue disease: Longitudinal clinical and serologic findings. Arthritis Rheum 42:899-909
11. Castro O, Hoque M, Brown BD (2003) Pulmonary hypertension in sickle cell disease: Cardiac catheterization results and survival. Blood 101:1257-1261
12. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354:579-587
13. Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I, Ducolone A, Ehrhart M, Kessler R, Weitzenblum E (2005) Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172:189-194
14. Chaouat A, Naeije R, Weitzenblum E (2008) Pulmonary hypertension in COPD. Eur Respir J 32:1371-1385
15. Chaves E (1966) The pathology of the arterial pulmonary vasculature in Manson's schistosomiasis. Dis Chest 50:72-77
16. Chin KM, Channick RN, Rubin LJ (2006) Is methamphetamine use associated with idiopathic pulmonary arterial hypertension Chest 130:1657-1663
17. Chu JW, Kao PN, Faul JL, Doyle RL (2002) High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest 122:1668-1673
18. Connolly HM, Crary JL,McGoonMD, Hensrud DD, Edwards BS, EdwardsWD, Schaff HV (1997) Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337:581-588
19. Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D, Cordier JF (2005) Combined pulmonary fibrosis and emphysema: A distinct underrecognised entity. Eur Respir J 26:586-593
20. Cottin V, Harari S, Humbert M, Mal H, Dorfmuller P, Jais X, Reynaud-Gaubert M, Prevot G, Lazor R, Taillé C, Lacronique J, Zeghmar S, Simonneau G, Cordier JF (2012) Pulmonary hypertension in lymphangioleiomyomatosis: Characteristics in 20 patients. Eur Respir J 40(3): 630-640
21. Dartevelle P, Fadel E, Mussot S, Chapelier A, Herve P, de Perrot M, Cerrina J, Ladurie FL, Lehouerou D, Humbert M, Sitbon O, Simonneau G (2004) Chronic thromboembolic pulmonary hypertension. Eur Respir J 23:637-648
22. Davis AM, Pierson RN, Loyd JE (2001) Mediastinal fibrosis. Semin Respir Infect 16:119-130
23. Dawson JK, Goodson NG, Graham DR, Lynch MP (2000) Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients. Rheumatology (Oxford) 39:1320-1325
24. Degano B, Guillaume M, Savale L, Montani D, Jas X, Yaici A, Le Pavec J, Humbert M, Simonneau G, Sitbon O (2010) HIV-associated pulmonary arterial hypertension: Survival and prognostic factors in the modern therapeutic era. AIDS 24:67-75
25. Delgado JF, Conde E, Sanchez V, Lopez-Rios F, Gomez-Sanchez MA, Escribano P, Sotelo T (2005) Gomez de la Camara A, Cortina J, de la Calzada CS. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail 7:1011-1016
26. Dorfmuller P, Humbert M, Perros F, Sanchez O, Simonneau G, Muller KM, Capron F (2007) Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 38:893-902
27. Dot JM, Sztrymf B, Yaici A, Dorfmuller P, Capron F, Parent F, Jais X, Sitbon O, Simonneau G, Humbert M (2007) Pulmonary arterial hypertension due to tumor emboli. Rev Mal Respir 24:359-366
28. Elliott CG, Glissmeyer EW, Havlena GT, Carlquist J, McKinney JT, Rich S, McGoon MD, Scholand MB, Kim M, Jensen RL, Schmidt JW, Ward K (2006) Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension. Circulation 113:2509-2515
29. Elstein D, Klutstein MW, Lahad A, Abrahamov A, Hadas-Halpern I, Zimran A (1998) Echocardiographic assessment of pulmonary hypertension in Gaucher's disease. Lancet 351: 1544-1546
30. Escamilla R, Hermant C, Berjaud J, Mazerolles C, Daussy X (1995) Pulmonary veno-occlusive disease in a HIV-infected intravenous drug abuser. Eur Respir J 8:1982-1984
31. Fartoukh M, Humbert M, Capron F, Maitre S, Parent F, Le Gall C, Sitbon O, Herve P, Duroux P, Simonneau G (2000) Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 161:216-223
32. Follath F, Burkart F, Schweizer W (1971) Drug-induced pulmonary hypertension Br Med J 5743:265-266
33. Fonseca GHH, Souza R, Salemi VC, Jardim CVP, Gualandro SFM (2012) Pulmonary hypertension diagnosed by right heart catheterization in sickle cell disease. Eur Respir J 39:112-118
34. Frachon I, Etienne Y, Jobic Y, Le Gal G, Humbert M, Leroyer C (2010) Benfluorex and unexplained valvular heart disease: A case-control study. PLoS One 5:e10128
35. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219-1263
36. Girerd B, Montani D, Coulet F, Sztrymf B, Yaici A, Jas X, Tregouet D, Reis A, Drouin-Garraud V, Fraisse A, Sitbon O, O'Callaghan DS, Simonneau G, Soubrier F, Humbert M (2010) Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care Med 181:851-861
37. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350:886-895
38. Goodwin RA, Nickell JA, Des Prez RM (1972) Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) 51:227-246
39. Guilpain P, Montani D, Damaj G, Achouh L, Lefrère F, Marfaing-Koka A, Dartevelle P, Simonneau G, Humbert M, Hermine O (2008) Pulmonary hypertension associated with myeloproliferative disorders: A retrospective study of ten cases. Respiration 76:295-302
40. Gunther S, Jas X, Maitre S, Bérezné A, Dorfmuller P, Seferian A, Savale L, Mercier O, Fadel E, Sitbon O, Mouthon L, Simonneau G, Humbert M, Montani D (2012) Computed tomography findings of pulmonary veno-occlusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. Arthritis Rheum 64(9):2995-3005
41. Gurtner HP (1979) Pulmonary hypertension, plexogenic pulmonary arteriopathy and the appetite depressant drug aminorex: Post or propter Bull Eur Physiopathol Respir 15:897-923
42. Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, Kahan A, Cabane J, Frances C, Launay D, Mouthon L, Allanore Y, Tiev KP, Clerson P, de Groote P, Humbert M (2005) Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study. Arthritis Rheum 52:3792-3800
43. Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, Mouthon L, Hatron PY, Jego P, Allanore Y, Tiev KP, Agard C, Cosnes A, Cirstea D, Constans J, Farge D, Viallard JF, Harle JR, Patat F, Imbert B, Kahan A, Cabane J, Clerson P, Guillevin L, Humbert M (2009) The 3-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study (ItinérAIR-Sclérodermie Study). Arthritis Rheum 60:1831-1839
44. Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP (1991) Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics. Gastroenterology 100:520-528
45. Hamaoka K, Nakagawa M, Furukawa N, Sawada T (1990) Pulmonary hypertension in type I glycogen storage disease. Pediatr Cardiol 11:54-56
46. Hatano S, Strasser T (1975) Primary pulmonary hypertension. Report on a WHO meeting. October 15-17, 1973. WHO, Geneva
47. Hoeper MM, Niedermeyer J, Hoffmeyer F, Flemming P, Fabel H (1999) Pulmonary hypertension after splenectomy Ann Intern Med 130:506-509
48. Hoffman JI, Rudolph AM (1965) The natural history of ventricular septal defects in infancy. Am J Cardiol 16:634-653
49. Humbert M (2012) The fifth world symposium on pulmonary hypertension will REVEAL the impact of registries. Eur Respir Rev 21:4-5
50. Humbert M, Simonneau G (2010) Vasodilators in patients with chronic obstructive pulmonary disease and pulmonary hypertension: Not ready for prime time. Am J Respir Crit Care Med 181:202-203
51. Humbert M, Maitre S, Capron F, Rain B, Musset D, Simonneau G (1998) Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis. Am J Respir Crit Care Med 157:1681-1685
52. Humbert M, Labrune P, Sitbon O, Le Gall C, Callebert J, Herve P, Samuel D, Machado R, Trembath R, Drouet L, Launay JM, Simonneau G (2002) Pulmonary arterial hypertension and type-I glycogen-storage disease: The serotonin hypothesis. Eur Respir J 20:59-65
53. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Eric Hachulla E, Simonneau G (2006) Pulmonary arterial hypertension in France: Results from a national registry. Am J Respir Crit Care Med 173:1023-1030
54. Humbert M, Khaltaev N, Bousquet J, Souza R (2007) Pulmonary hypertension: From an orphan disease to a public health problem. Chest 132:365-367
55. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaci A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jas X, Montani D, Souza R, Simonneau G (2010a) Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122:156-163
56. Humbert M, Sitbon O, Yaici A, Montani D, O'Callaghan DS, Jas X, Parent F, Savale L, Natali D, Gunther S, Chaouat A, Chabot F, Cordier JF, Habib G, Gressin V, Jing ZC, Souza R, Simonneau G (2010b) Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 36:549-555
57. Jais X, Ioos V, Jardim C, Sitbon O, Parent F, Hamid A, Fadel E, Dartevelle P, Simonneau G, Humbert M (2005) Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax 60:1031-1034
58. Jais X, Launay D, Yaici A, Le Pavec J, Tcherakian C, Sitbon O, Simonneau G, Humbert M (2008) Immunosuppressive therapy in lupus-and mixed connective tissue disease-associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases. Arthritis Rheum 58:521-531
59. Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, Channick RN, Fedullo PF, Auger WR (2003) Pulmonary endarterectomy: Experience and lessons learned in 1,500 cases. Ann Thorac Surg 76:1457-1462, discussion 62-64
60. Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Brown RS Jr, Fallon MB (2008) Clinical risk factors for portopulmonary hypertension. Hepatology 48:196-203
61. Kim NH (2006) Assessment of operability in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 3:584-588
62. Kovacs G, Berghold A, Scheidl S, Olschewski H (2009) Pulmonary arterial pressure during rest and exercise in healthy subjects: A systematic review. Eur Respir J 34:888-894
63. Lantuejoul S, Sheppard MN, Corrin B, Burke MM, Nicholson AG (2006) Pulmonary venoocclusive disease and pulmonary capillary hemangiomatosis: A clinicopathologic study of 35 cases. Am J Surg Pathol 30:850-857
64. Lapa M, Dias B, Jardim C, Fernandes CJ, Dourado PM, Figueiredo M, Farias A, Tsutsui J, Terra-Filho M, Humbert M, Souza R (2009) Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 119:1518-1523
65. Launay D, Souza R, Guillevin L, Hachulla E, Pouchot J, Simonneau G, Humbert M (2006) Pulmonary arterial hypertension in ANCA-associated vasculitis. Sarcoidosis Vasc Diffuse Lung Dis 23:223-228
66. Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M (2007) Pulmonary arterial hypertension: A rare complication of primary Sjogren syndrome: Report of 9 new cases and review of the literature. Medicine (Baltimore) 86:299-315
67. Le Pavec J, Souza R, Herve P, Lebrec D, Savale L, Tcherakian C, Jais X, Yaici A, Humbert M, Simonneau G, Sitbon O (2008) Portopulmonary hypertension: Survival and prognostic factors. Am J Respir Crit Care Med 178:637-643
68. Le Pavec J, Lorillon G, Jas X, Tcherakian C, Feuillet S, Dorfmuller P, Simonneau G, Humbert M, Tazi A (2012) Pulmonary Langerhans cell histiocytosis associated pulmonary hypertension: Clinical characteristics and impact of pulmonary arterial hypertension therapies. Chest 142 (5):1150-1157
69. Li JH, Safford RE, Aduen JF, Heckman MG, Crook JE, Burger CD (2007) Pulmonary hypertension and thyroid disease. Chest 132:793-797
70. Loyd JE, Tillman BF, Atkinson JB, Des Prez RM (1988) Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore) 67:295-310
71. Mayer E, Kriegsmann J, Gaumann A, Kauczor HU, Dahm M, Hake U, Schmid FX, Oelert H (2001) Surgical treatment of pulmonary artery sarcoma. J Thorac Cardiovasc Surg 121:77-82
72. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA (2000) HIV-Related pulmonary hypertension: Analytic review of 131 cases. Chest 118:1133-1141
73. Montani D, Achouh L, Dorfmuller P, Le Pavec J, Sztrymf B, Tcherakian C, Rabiller A, Haque R, Sitbon O, Jais X, Dartevelle P, Maitre S, Capron F, Musset D, Simonneau G, Humbert M (2008) Pulmonary veno-occlusive disease: Clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore) 87:220-233
74. Montani D, Price LC, Dorfmuller P, Achouh L, Jais X, Yaici A, Sitbon O, Musset D, Simonneau G, HumbertM(2009) Pulmonary veno-occlusive disease. Eur Respir J 33:189-200
75. Montani D, Coulet F, Girerd B, Eyries M, Bergot E, Mal H, Biondi G, Dromer C, Hugues T, Marquette C, O'Connell C, O'Callaghan DS, Savale L, Jas X, Dorfmuller P, Begueret H, Bertoletti L, Sitbon O, Bellanné-Chantelot C, Zalcman G, Simonneau G, Humbert M, Soubrier F (2011) Pulmonary hypertension in patients with neurofibromatosis type I. Medicine (Baltimore) 90:201-211
76. Montani D, Bergot E, Gunther S, Savale L, Bergeron A, Bourdin A, Bouvaist H, Canuet M, Pison C, Macro M, Poubeau P, Girerd B, Natali D, Guignabert C, Perros F, O'Callaghan DS, Jas X, Tubert-Bitter P, Zalcman G, Sitbon O, Simonneau G, Humbert M (2012) Pulmonary arterial hypertension in patients treated by dasatinib. Circulation 125:2128-2137
77. Moraes DL, Colucci WS, Givertz MM (2000) Secondary pulmonary hypertension in chronic heart failure: The role of the endothelium in pathophysiology and management. Circulation 102:1718-1723
78. Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, Black CM, Coghlan JG (2003) Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach. Ann Rheum Dis 62:1088-1093
79. Nakhoul F, Yigla M, Gilman R, Reisner SA, Abassi Z (2005) The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant 20:1686-1692
80. Nunes H, Humbert M, Sitbon O, Morse JH, Deng Z, Knowles JA, Le Gall C, Parent F, Garcia G, Herve P, Barst RJ, Simonneau G (2003) Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 167: 1433-1439
81. Nunes H, Humbert M, Capron F, Brauner M, Sitbon O, Battesti JP, Simonneau G, Valeyre D (2006) Pulmonary hypertension associated with sarcoidosis: Mechanisms, haemodynamics and prognosis. Thorax 61:68-74
82. Opravil M, Sereni D (2008) Natural history of HIV-associated pulmonary arterial hypertension: Trends in the HAART era. AIDS 22:S35-S40
83. Opravil M, Pechere M, Speich R, Joller-Jemelka HI, Jenni R, Russi EW, Hirschel B, Luthy R (1997) HIV-associated primary pulmonary hypertension: A case control study. Am J Respir Crit Care Med 155:990-995
84. Oudiz RJ (2007) Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med 28:233-241
85. Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, Bennani S, Savale L, Adnot S, Maitre B, Yaici A, Hajji L, O'Callaghan DS, Clerson P, Girot R, Galacteros F, Simonneau G (2011) A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med 365:44-53
86. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350:2257-2264
87. Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D'Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Jas X, Simonneau G (2011) Chronic thromboembolic pulmonary hypertension (CTEPH): Results from an international prospective registry. Circulation 124:1973-1981
88. Pizzo CJ (1980) Type I, glycogen storage disease with focal nodular hyperplasia of the liver and vasoconstrictive pulmonary hypertension. Pediatrics 65:341-343
89. Rabiller A, Jais X, Hamid A, Resten A, Parent F, Haque R, Capron F, Sitbon O, Simonneau G, Humbert M (2006) Occult alveolar haemorrhage in pulmonary veno-occlusive disease. Eur Respir J 27:108-113
90. Roberts KE, Hamele-Bena D, Saqi A, Stein CA, Cole RP (2003) Pulmonary tumor embolism: A review of the literature. Am J Med 115:228-232
91. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB (2004) Pulmonary-hepatic vascular disorders. Eur Respir J 24:861-880
92. Rubin LJ, Hoeper MM, Klepetko W, Galie N, Lang IM, Simonneau G (2006) Current and future management of chronic thromboembolic pulmonary hypertension: From diagnosis to treatment responses. Proc Am Thorac Soc 3:601-607
93. Sanchez O, Sitbon O, Jas X, Simonneau G, Humbert M (2006) Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 130:182-189
94. Savale L, Chaumais MC, Cottin V, Bergot E, Frachon I, Prevot G, Pison C, Dromer C, Poubeau P, Lamblin N, Habib G, Reynaud-Gaubert M, Bourdin A, Sanchez O, Tubert-Bitter P, Jas X, Montani D, Sitbon O, Simonneau G, Humbert M (2012) Pulmonary hypertension associated with benfluorex exposure. Eur Respir J 40(5):1164-1172
95. Seferian A, Jas X, Creuze N, Savale L, Humbert M, Sitbon O, Simonneau G, Montani D (2012) Mediastinal fibrosis mimicking proximal chronic thromboembolic disease. Circulation 125: 2045-2047
96. Shorr AF, Helman DL, Davies DB, Nathan SD (2005) Pulmonary hypertension in advanced sarcoidosis: Epidemiology and clinical characteristics. Eur Respir J 25:783-788
97. Simonneau G, Fartoukh M, Sitbon O, Humbert M, Jagot JL, Herve P (1998) Primary pulmonary hypertension associated with the use of fenfluramine derivatives. Chest 114:195S-199S
98. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54:S43-S54
99. Sitbon O, Lascoux-Combe C, Delfraissy JF, Yeni PG, Raffi F, De Zuttere D, Gressin V, Clerson P, Sereni D, Simonneau G (2008) Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 177:108-113
100. Souza R, Humbert M, Sztrymf B, Jais X, Yaici A, Le Pavec J, Parent F, Herve P, Soubrier F, Sitbon O, Simonneau G (2008) Pulmonary arterial hypertension associated with fenfluramine exposure: Report of 109 cases. Eur Respir J 31:343-348
101. Speich R, Jenni R, Opravil M, Pfab M, Russi EW (1991) Primary pulmonary hypertension in HIV infection. Chest 100:1268-1271
102. Stewart DR, Cogan JD, Kramer MR, Miller WT Jr, Christiansen LE, Pauciulo MW, Messiaen LM, Tu GS, Thompson WH, Pyeritz RE, Ryu JH, Nichols WC, Kodama M, Meyrick BO, Ross DJ (2007) Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy Chest 132:798-808
103. Suntharalingam J, Treacy CM, Doughty NJ, Goldsmith K, Soon E, Toshner MR, Sheares KK, Hughes R, Morrell NW, Pepke-Zaba J (2008) Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest 134:229-236
104. Sztrymf B, Coulet F, Girerd B, Yaici A, Jais X, Sitbon O, Montani D, Souza R, Simonneau G, Soubrier F, Humbert M (2008) Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med 177:1377-1383
105. Tanaka E, Harigai M, Tanaka M, Kawaguchi Y, Hara M, Kamatani N (2002) Pulmonary hypertension in systemic lupus erythematosus: Evaluation of clinical characteristics and response to immunosuppressive treatment. J Rheumatol 29:282-287
106. Tapson VF, Humbert M (2006) Incidence and prevalence of chronic thromboembolic pulmonary hypertension: From acute to chronic pulmonary embolism. Proc Am Thorac Soc 3:564-567
107. Thabut G, Dauriat G, Stern JB, Logeart D, Levy A, Marrash-Chahla R, Mal H (2005) Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 127:1531-1536
108. Theise ND, Ursell PC (1990) Pulmonary hypertension and Gaucher's disease: Logical association or mere coincidence Am J Pediatr Hematol Oncol 12:74-76
109. Walker AM, Langleben D, Korelitz JJ, Rich S, Rubin LJ, Strom BL, Gonin R, Keast S, Badesch D, Barst RJ, Bourge RC, Channick R, Frost A, Gaine S, McGoon M, McLaughlin V, Murali S, Oudiz RJ, Robbins IM, Tapson V, Abenhaim L, Constantine G (2006) Temporal trends and drug exposures in pulmonary hypertension: An American experience. Am Heart J 152:521-526
110. Weitzenblum E, Hirth C, Ducolone A, Mirhom R, Rasaholinjanahary J, Ehrhart M (1981) Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 36:752-758
111. Whyte K, Hoette S, Hervé P, Montani D, Jas X, Parent F, Savale L, Natali D, O'Callaghan DS, Garcia G, Sitbon O, Simonneau G, Humbert M, Chemla D (2012) The association between resting and mild-to-moderate exercise pulmonary artery pressure. Eur Respir J 39:313-318
112. Wood P (1958) The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. I. Br Med J 2:701-709
113. Yigla M, Nakhoul F, Sabag A, Tov N, Gorevich B, Abassi Z, Reisner SA (2003) Pulmonary hypertension in patients with end-stage renal disease. Chest 123:1577-1582
114. Zener JC, Hancock EW, Shumway NE, Harrison DC (1972) Regression of extreme pulmonary hypertension after mitral valve surgery. Am J Cardiol 30:820-826
115. Zuber JP, Calmy A, Evison JM, Hasse B, Schiffer V, Wagels T, Nuesch R, Magenta L, Ledergerber B, Jenni R, Speich R, Opravil M (2004) Pulmonary arterial hypertension related to HIV infection: Improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 38:1178-1185